URAS, C. Et Al. 2022. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up. BMC CANCER , vol.22, no.1 .

URAS, C., Cabioglu, N., TOKAT, F., ER, Ö., KARA, H., KORKMAZ, T., ... Bese, N.(2022). Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up. BMC CANCER , vol.22, no.1.

URAS, Cihan Et Al. "Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up," BMC CANCER , vol.22, no.1, 2022

URAS, Cihan Et Al. "Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up." BMC CANCER , vol.22, no.1, 2022

URAS, C. Et Al. (2022) . "Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up." BMC CANCER , vol.22, no.1.

@article{article, author={Cihan URAS Et Al. }, title={Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up}, journal={BMC CANCER}, year=2022}